EDGAR Filing Documents for 0001144204-13-052062

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001144204-13-052062

Filing Date

2013-09-24

Accepted

2013-09-24 09:07:49

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 424B5	v355574_424b5.htm	424B5	343471
2	GRAPHIC	tlogo.jpg	GRAPHIC	30605
	Complete submission text file	0001144204-13-052062.txt		386867

Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017

Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500

NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)